|
|
Article: Newly Published Data Show Efficacy and Safety of LUNESTA(R) in Elderly Patients with Insomnia.(Clinical report)
- Article from:
- Business Wire
- Article date:
- October 12, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Data Showed Improvements in Both Polysomnographic and Patient-Reported Sleep Measures
MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced the publication of results of a large, randomized, double-blind, placebo-controlled, two-week study of LUNESTA([R]) brand of eszopiclone for the treatment of insomnia in elderly patients. The study was conducted in 49 centers across the U.S. and included elderly patients (64-86 years of age; n=264) who met DSM-IV([R]) 1 criteria for primary insomnia and screening polysomnographic (PSG; a type of study conducted in a sleep laboratory) criteria. Patients were randomized to two weeks of nightly treatment with either ...